References
- Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–74
- Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
- WHO. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: World Health Organization; 2011
- Dekker GA, Sibai BM. Pathogenesis and etiology of preeclampsia. Am J Obstet Gynecol 1998;179:1359–75
- Matjevic R. Meekins JW, Walkinshaw SA, et al Spiral artery blood flow in central areas of placental bed in the second trimester. Obstet Gynecol 1995;86:289–92
- Pijnenborg R. Trophoblast invasion. Reprod Med Rev 1994;3:53–73
- Niebroj-Dobosz I. Tenascin C in human cardiac pathology. Clin Chim Acta 2012;413:1516–18
- Jones PL, Jones FS. Tenascin-C in devolopment and disease: gene regülation and cell function. Matrix Biol 2000;19:581–96
- Hsia HC, Schwarzbauer JE. Meet the tenascins: multifunctionals and mysterious. J Biol Chem 2005;280:26641–4
- Von Holst A. Tenascin-C in stem cell niches: redundant, permissive or instructive? Cell Tissue Organ 2008;188:170–7
- Jones PL, Rabinovitch M. Tenascin C is induced with progressive pulmonary vasculer disaese in rats and is functionally related to increased smooth muscle cell proliferation. Cire Res 1996;79:1131–42
- Wallner K, Li C, Shah PK, et al. Tenascin C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation 1999;99:1284–9
- Imanaka-Yoshida K, Hiroe M, Yoshida T. Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histol Hisopathol 2004;19:517–25
- Tucker RP, Chiquet-Ehrismann R. The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 2009;193:888–92
- American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol 2002;77:67–75
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:1–22
- Madazli R, Somunkiran A, Calay Z, et al. Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doopler velocimetries of the uterine and umbilical arteries. Placenta 2003;24:510–16
- Madazli R, Benian A, Aydın S, et al. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in preeclampsia. J Obstet Gynecol 2002;22:477–80
- Madazli R, Benian A, Gümüştaş K, et al. Lipid peroxidation and antioxidants in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1999;85:205–8
- Genc H, Uzun H, Benian A, et al. Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk. Arch Gynecol Obstet 2011;284:1367–73
- Sibai BM, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
- Poston L, Raijmakers MTM. Trophoblast oxidative stres, antioxidants and pregnancy out come – a review. Placenta 2004;25:72–8
- Madazli R, Benian A, Ilvan S, Calay Z. Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without preeclampsia. J Obstet Gynecol 2006;26:5–10
- Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200–4
- Gollodge J, Clancy P, Maguire J, et al. The role of tenascin C in cardiovascular disease. Cardiovasc Res 2011;92:19–28
- Castellucci M, Classen-Linke I, Mühlhauser J, et al. The human placenta: a model for tenascin expression. Histochemistry 1991;95:449–58
- Borsi L, Carnemolla B, Ponassi M, Zardi L. Steady-state levels of different tenascin mRNAs in various normal human tissues. Cell Biol Int 1993;17:325–9
- Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506